Literature DB >> 3480531

A conserved domain regulates interactions of the v-fps protein-tyrosine kinase with the host cell.

J E DeClue1, I Sadowski, G S Martin, T Pawson.   

Abstract

All cytoplasmic protein-tyrosine kinases (PTKs) share a noncatalytic domain, termed SH2, which comprises approximately 100 residues located immediately N-terminal to the kinase domain. A linker in the AX9m mutant of Fujinami avian sarcoma virus (FSV) introduces a dipeptide insertion into the SH2 domain of the P130gag-fps PTK, which abolishes its ability to transform Rat-2 cells. However, at 36 degrees C AX9m FSV elicits focus formation and agar colony formation in infected chicken embryo fibroblasts (CEF) with single hit kinetics. At 41.5 degrees C AX9m FSV is nontransforming for CEF, and the mutant is therefore both host and temperature dependent for transforming activity. Both in vitro and in vivo, the specific kinase activity of AX9m FSV P130gag-fps, measured by autophosphorylation and phosphorylation of exogenous substrates, correlated with transforming activity. The consequences of the AX9m mutation for enzymatic function and transforming activity therefore depend on the cellular environment in which the altered v-fps protein is expressed. We conclude that the SH2 domain directs the interaction of the P130gag-fps catalytic domain with cellular proteins such as substrates for phosphorylation or regulators of kinase activity important for its transforming ability.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3480531      PMCID: PMC299692          DOI: 10.1073/pnas.84.24.9064

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Transformation by Rous sarcoma virus: effects of src gene expression on the synthesis and phosphorylation of cellular polypeptides.

Authors:  K Radke; G S Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

2.  Mutants of Rous sarcoma virus with extensive deletions of the viral genome.

Authors:  G S Martin; K Radke; S Hughes; N Quintrell; J M Bishop; H E Varmus
Journal:  Virology       Date:  1979-07-30       Impact factor: 3.616

3.  Transformation-defective mutants of Rous sarcoma virus with src gene deletions of varying length.

Authors:  S Kawai; P H Duesberg; H Hanafusa
Journal:  J Virol       Date:  1977-12       Impact factor: 5.103

4.  Phosphorylation of talin at tyrosine in Rous sarcoma virus-transformed cells.

Authors:  J E DeClue; G S Martin
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

5.  Catalytic and non-catalytic domains of the Fujinami sarcoma virus P130gag-fps protein-tyrosine kinase distinguished by the expression of v-fps polypeptides in Escherichia coli.

Authors:  I Sadowski; T Pawson
Journal:  Oncogene       Date:  1987-05       Impact factor: 9.867

6.  A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps.

Authors:  I Sadowski; J C Stone; T Pawson
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

7.  Four different classes of retroviruses induce phosphorylation of tyrosines present in similar cellular proteins.

Authors:  J A Cooper; T Hunter
Journal:  Mol Cell Biol       Date:  1981-05       Impact factor: 4.272

8.  A strain of Fujinami sarcoma virus which is temperature-sensitive in protein phosphorylation and cellular transformation.

Authors:  T Pawson; J Guyden; T H Kung; K Radke; T Gilmore; G S Martin
Journal:  Cell       Date:  1980-12       Impact factor: 41.582

9.  Complementation rescue of Rous sarcoma virus from transformed mammalian cells by polyethylene glycol-mediated cell fusion.

Authors:  K S Steimer; D Boettiger
Journal:  J Virol       Date:  1977-07       Impact factor: 5.103

10.  Identification of an amino terminal domain required for the transforming activity of the Rous sarcoma virus src protein.

Authors:  V W Raymond; J T Parsons
Journal:  Virology       Date:  1987-10       Impact factor: 3.616

View more
  32 in total

1.  Src homology region 2 domains direct protein-protein interactions in signal transduction.

Authors:  M F Moran; C A Koch; D Anderson; C Ellis; L England; G S Martin; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo.

Authors:  B J Mayer; P K Jackson; R A Van Etten; D Baltimore
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

3.  Multiple SH2-mediated interactions in v-src-transformed cells.

Authors:  C A Koch; M F Moran; D Anderson; X Q Liu; G Mbamalu; T Pawson
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

Review 4.  The discovery of modular binding domains: building blocks of cell signalling.

Authors:  Bruce J Mayer
Journal:  Nat Rev Mol Cell Biol       Date:  2015-09-30       Impact factor: 94.444

5.  The common src homology region 2 domain of cytoplasmic signaling proteins is a positive effector of v-fps tyrosine kinase function.

Authors:  C A Koch; M Moran; I Sadowski; T Pawson
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

6.  SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange.

Authors:  S Felder; M Zhou; P Hu; J Ureña; A Ullrich; M Chaudhuri; M White; S E Shoelson; J Schlessinger
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

7.  En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase.

Authors:  A J Muller; A M Pendergast; K Parmar; M H Havlik; N Rosenberg; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  The v-Src SH3 domain binds phosphatidylinositol 3'-kinase.

Authors:  X Liu; L E Marengere; C A Koch; T Pawson
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

9.  Delineation of functional determinants in the transforming protein of Fujinami sarcoma virus.

Authors:  K A Johnson; J C Stone
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

10.  Effects of transformation by v-fps on nucleoside transport in Rat-2 fibroblasts.

Authors:  K A Meckling-Gill; C E Cass
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.